Tshawb Nrhiav | Blue Cross MN

Nthuav pom cov txiaj ntsig tshwm sim 1561 - 1570 ntawm 4179

Tus kws kho mob

QP72-20 MHCP Pharmacy Benefit Update – Pharmacy Benefit Exclusion for Anjeso™, Fetroja®, Herzuma®, Ontruzant®, Potassium Phosphates, Scenesse® and Trazimera™

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020

Tus kws kho mob

QP71-20 MHCP Pharmacy Benefit Update: Pharmacy Benefit Exclusion for Phesgo™, Uplizna™, and Zepzelca™

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020

Tus kws kho mob

QP75-20 Commercial Pharmacy Benefit Exclusion for Aralast®NP, Eylea®, Glassia®, Lucentis®, Prolastin®-C, and UpliznaTM

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020

Tus kws kho mob

QP70-20 In-Home Test Kits 2020 Program Details for Medicare Advantage and SecureBlue Members

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 12, 2020

Tus kws kho mob

Copy of providers-COVID19_FAQ_8-6-2020.pdf

Nyeem Ntxiv

Tus kws kho mob

Upcoming policies effective October 5, 2020

Nyeem Ntxiv

Tus kws kho mob

Reduction Mammoplasty Commercial Pre-Authorization Request Form (Medical Policy IV-32) (PDF)

Nyeem Ntxiv

Tus kws kho mob

P28R1-20 Update: Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020

Tus kws kho mob

P57-20 Site of Service Program Updates for Selected Specialty Medical Drugs for Commercial Subscribers: Medical Policy XI-06

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020

Tus kws kho mob

P63-20 Prior Authorization Updates for Skilled Nursing Facility Admissions

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 03, 2020